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Purpose: In Hypertension, left ventricle (LV) hypertrophy (LVH) is a
potent prognostic factor to predict outcome. Proton Nuclear Magnetic Reso-
nance (1H NMR) spectroscopy, a new technique for analyzing blood metabo-
lites profiles has proved to be one of the most powerful technologies in
metabonomic studies of biofluids. We investigated for plasma LVH biomar-
kers of human Hypertensive Heart Disease.
Methods: In this prospective study, 96 hypertensive patients (48 LVH vs.
48 normal LV size) and 24 healthy controls were selected from 2007 to 2009
for plasma 1H NMR-based metabonomic profiling. A multivariate analysis of
the spectral data set was performed by using the Partial Least Squares Dis-
criminant Analysis (PLS-DA).
Results: PLS-DA Scores plot of spectral data revealed sample clustering
according to the clinical state. PLS-DA loading plot reveals the variables
influencing that discrimination which have been identified as signals coming
from the methylene (-CH2) and methyl (-CH3) moieties of aliphatic chain
from plasma lipids. Thus, the CH2/CH3 ratio which is an indicator of mean
length of the aliphatic lipid chain was significantly higher for the LVH group
of patients (p<0.01). None difference was observed between two hypertensive
groups for blood level of Cholesterol or acyl chain.
Discussion: LVH is associated with profound metabolic changes. Indeed,
fatty acid (FA) oxidation is lowered in LVH as a consequence of PPAR alpha
transcription factor underexpression. In particular, a selective impairment of
long chain FA oxidization via a down regulation of CPT1 has been demon-
strated in animal models. These observations could explain changes in lipid
profiles observed in LVH’s group plasma. 
Conclusion: Thus, the mean length increase of the aliphatic lipid chain we
measured in the plasma from LVH patients is in agreement with previous
studies on cardiomyocytes that showed a lipid metabolism alteration with a
lower oxidation rate for long chain FA.
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Objective: Cardiorenal anaemia syndrome is known to increase mortality
and morbidity in patients with CHF. The role of the sympathetic nervous
system and related-reflexes in the pathophysiology remains unknown.
Design and Methods: The prospective study was conducted at the Inten-
sive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France. We
studied 15 patients with CRA syndrome (age: 66.5±3.1 years; mean BMI:
24.12±0.9 kg/m2) and 15 control patients with CHF alone matched for age,
gender distribution, type of cardiomyopathy, left ventricular ejection fraction
(LVEF) and BMI. We compared sympathetic nerve activity (MSNA), sympa-
thetic baroreflex function (assessed by the slope of the relationship between
muscle sympathetic nerve activity (MSNA) and diastolic blood pressure) and
its modulation by peripheral chemoreflex, in both groups.
Results: Baseline MSNA was significantly elevated in CHF patients with
CRA syndrome compared with patients with CHF alone (83.1±4.6 versus
64.9±2.9 bursts/100 heart beats; P<0.01) and sympathetic baroreflex function
impaired (2.69±0.44 versus 5.25±0.60 %/mmHg; P<0.01). In comparaison
with control, chemoreflex deactivation with administration of 100% oxygen
led to a significant decrease in muscle sympathetic nerve activity and an
increase in arterial baroreflex sensitivity in patients with CRA syndrome.
Conclusion: CRA syndrome is associated with elevated sympathetic
activity mediated by both baroreflex impairment and tonic activation of
peripheral chemoreflex. The latter, through direct interaction with sympathetic
baroreflex function subsequently contributes to further activation of the SNS
tone. Altogether, mechanisms described in this study could partly explain how
CRAS contributes to the progression of CHF and increases morbidity and
mortality in these patients.
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Background: Acute myocardial infarction (AMI) is the clinical manifesta-
tion of the chronic development of coronary artery atheroma, with the final
process of plaque rupture and coronary thrombosis. Plasma lipoprotein (a)
(Lp(a)) levels are mainly genetically determined. The C93T and G121A poly-
morphisms are a naturally occurring variant of the LPA gene that may influ-
ence Lp(a) concentration. The role of Lp(a) in the pathogenesis of myocardial
infarction has not been established.
Methods: A one hundred sixty-eight AMI patients compared to 169 healthy
controls.
Results: No association between LPA C93T genotypes and AMI was
found. The frequencies of the GG, GA and AA genotypes of LPA G121A
polymorphism were not significantly different in AMI patients and in healthy
controls (45.2 %, 48.2%, 6.6 % vs 41.7%, 49.4%, 8.9%, P=0.880). In multi-
variate logistic regression analysis with covariates including traditional risk
factors (diabetes, hypertension, smoking and cholesterol) and, The C93T and
G121A polymorphisms, hypertension was independently associated with
increased risk of AMI (OR=3.5, P=0.058; OR=0.78, P=0.103 respectively).
Conclusion: The C93T and G121A polymorphisms of the LPA gene is not
associated with susceptibility to acute myocardial infarction.
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Background: The prevention of atherosclerosis depends on the high-
density lipoprotein (HDL) capacity to stimulate the efflux of unesterified cho-
lesterol from cell. The high density lipoprotein Anionic Peptide Factor
(HDL3-APF) was previously described as an apolipoprotein that promotes the
reverse cholesterol transport. This was demonstrated in vitro conditions and in
animal model. On another side, it was shown that reverse cholesterol transport
was altered in type 2 diabetes with or without coronary artery disease (CAD).
Patients and Methods: We investigated a possible association between
plasma HDL3-APF concentration, cholesterol efflux from Fu5AH cells and
cholesteryl ester transfer protein (CETP) activity in type 2 diabetic patients
with CAD (n=36), those without CAD (n=20), and 37 healthy subjects as a
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sex- and age-matched control. Results: Plasma HDL3-APF concentrations
were decreased in all patients: p<0.01 in diabetics with CAD compared to
controls. Cellular cholesterol efflux level was decreased by 13% and 18%,
respectively in diabetics and diabetics with CAD, compared to controls
(p<0.01 and p<0.001; respectively). However, Cholesteryl ester transfer pro-
tein (CETP) activity was increased in all patients groups (p<0.05 in diabetics
with CAD compared to controls). Multiple linear regression analysis shows
that only cholesterol efflux level was independently and positively related
only to HDL3-APF concentrations in whole population and controls (respec-
tively p=0.0005 and p<0.0001) but not in patients.
Conclusions: our results suggest that HDL3-APF is likely to be a key inde-
pendent factor for promoting cellular cholesterol efflux in healthy subjects and
improve reverse cholesterol transport. However this association is altered in type
2 diabetes with and without CAD. CETP activity was neither related to plasma
HDL3-APF concentrations nor to the cellular cholesterol efflux levels.
